A live attenuated Yersinia pestis (Pasteurella pestis) vaccine strain designated EV51f, which had been passaged through guinea pigs previously treated with ferrous sulfate, was shown to be pathogenic for African green vervet monkeys (Cercopithecus aethiops pygerythrus), but not for guinea pigs. The 
In recent years, plague, caused by Yersinia pestis (formerly Pasteurella pestis), has decreased as a health hazard throughout the world with the exception of a few areas such as Brazil, Bolivia, Congo, and the Republic of Vietnam. Sporadic outbreaks, however, still occur in many other areas. A need for vaccination against plague still exists in protecting laboratory staff, field personnel working in enzootic areas, and certain other high-risk groups in endemic areas under conditions such as those of war existing in Vietnam.
Experimental work on live attenuated plague vaccines using genetically related Y. pestis strains established the importance of virulence determinants in immunity to plague in white mice, guinea pigs, and rabbits (3, 4) . The strains which were most immunogenic in both mice and guinea pigs were found to have the ' Present address: Department of Microbiology, Faculty of Medicine, University of Natal, Durban, South Africa.
virulence characters of the two vaccine strains used most widely in man, i.e., EV76 (10) and Tjiwidej (18) .
Although much is known about the virulence determinants and protective antigens of Y. pestis, it was suggested (2) that there are probably other antigenic components which are important in immunity but have not been identified. Thus, although killed vaccines may possess all the known antigenic components, live vaccines possess the potential of producing antigenic components in vivo which are not formed in vitro. This may account for the higher immunogenicity of most living attenuated Y. pestis strains than killed vaccines in experimental animals.
Different attenuated plague strains have different immunizing capacities associated with the method of maintaining the cultures (7, 12) . A successful method which was employed to stabilize attenuated vaccines antigenically and to increase the immunogenic capacity has been 876 on October 24, 2017 by guest http://iai.asm.org/ Downloaded from to passage the strain through guinea pigs previously treated with ferrous sulfate (12) .
The adoption of a standardized plan to evaluate any plague vaccine first on rodents, and then on nonhuman primates, and finally on human subjects (14) Vaccine. Details of the vaccine preparation have been previously described (14) . Serial There was a marked decline in the titers of both HA and MPI antibodies between day 28 and 163 after vaccination. However, at the time of virulent challenge all but one monkey had significant hemagglutinin titers, and 2 had MPI values below 10, indicative of a high level of immunity. There was no apparent correlation between the HA titer and protection against virulent challenge, as a titer of 1:128 failed to protect, whereas one animal, which had failed to convert to a positive HA titer, survived. The three which succumbed had MPI values of 15 or over, but one survivor had a value of 17. The pathogenicity of the EV51f strain and protection conferred against virulent Y. pestis shows marked differences in vervets, macaques, and guinea pigs. It is known that P-(pigment factor negative) derivatives of virulent Y. pestis strains show the high virulence of their P+ parents in mice which had been injected with small, nontoxic amounts of iron salts (11) . The injected iron not only reduces the mean lethal dose (LD,0) value to that of virulent strains, but also permits growth in vivo to the large populations characteristic of virulent infections. Burrows (2) concluded that injected iron provides an essential element not sufficiently available to P-bacilli in vivo. As the attenuated EV76 Y. pestis strain is fully virulent in mice previously inoculated with ferrous sulfate (11), the passage of this strain through iron-treated guinea pigs would, therefore, select a population of bacilli lacking only the virulence determinant for which iron compensates (P). Differences in the pathogenicity of the EV51f strain in different animal species would therefore most likely be a reflection of the availability of iron. In African green vervet monkeys, this availability is apparently such that low doses of these bacilli are able to on October 24, 2017 by guest http://iai.asm.org/ Downloaded from multiply and invade and cause death of a certain proportion (26% in our study) of individuals, whereas the others become ill, as reflected by a rise in temperature and white cell count. Multiplication of the EV51f bacilli in the monkeys was confirmed by positive blood cultures 4 to 11 days after s.c. inoculation of vaccine doses as low as 102 bacilli. This would explain why all doses cause similar HA and MPI serological responses and similar rates of protection against virulent challenge 6 months after vaccination. It is likely that the availability of iron in guinea pigs is less than in vervet monkeys but sufficient for multiplication of the organisms to be immunogenic, yet not sufficient for the bacilli to reach a lethal level in the animal, which is estimated to be 1.6 x 1011 virulent organisms (9) . A similar relationship between virulence and availability of iron also appears to exist in other species of the genus Yersinia (19) .
The finding that the EV51f strain is pathogenic in certain nonhuman primates and not in others has important consequences for the evaluation of plague vaccines. It has been stated (5) that a demonstration of non-pathogenicity of a bacterial strain toward a presumed sensitive animal species need not assure its safety for man. This followed the finding that a number of Y. pestis isolates from Brazil had attenuated virulence in guinea pigs but not in white mice. The host specificity of these isolates was found to be determined by a nutritional requirement identified as asparagine. It has long been realized that the response of man to plague vaccines is not the same as that of guinea pigs and white mice, and it was suggested by Otten (17) that the monkey appeared to be the most suitable animal for their investigation, but he also recognized that different monkey species vary in their susceptibility to plague. The results of the present work agree with those of Meyer (14) and other workers in that the response of guinea pigs and African green vervet monkeys to live attenuated plague vaccines was shown to be very different, and it probably differs in both from the response in man.
